Blankenship et al v. Bayer Corporation et al
Filing
26
ORDER REMANDING ACTION by Hon. William Alsup granting 25 Stipulation.(whalc1, COURT STAFF) (Filed on 6/20/2017)
1
4
Laura J. Baughman, CA SBN 263944
Baron & Budd, P.C.
3102 Oak Lawn Avenue, Suite 1100
Dallas, Texas 75219
Telephone: (214) 521-3605
Facsimile: (214) 520-1181
Email: lbaughman@baronbudd.com
5
Attorney for Plaintiffs
6
Alycia A. Degen, SBN 211350
adegen@sidley.com
Bradley J. Dugan, SBN 271870
bdugan@sidley.com
SIDLEY AUSTIN LLP
555 West Fifth Street, Suite 4000
Los Angeles, California 90013
Telephone: 1-213-896-6000
Facsimile: 1-213-896-6600
2
3
7
8
9
10
11
12
Attorneys for Defendants and Specially Appearing
Defendants Bayer Corporation, Bayer Essure Inc.,
Bayer HealthCare LLC, Bayer HealthCare
Pharmaceuticals Inc.
13
14
15
UNITED STATES DISTRICT COURT
16
NORTHERN DISTRICT OF CALIFORNIA
17
18
19
LEANNA BLANKENSHIP, et al.;
20
21
22
23
24
25
26
27
Plaintiffs,
v.
CASE NO. 3:17-cv-02230-WHA
JOINT STIPULATION TO REMAND;
[PROPOSED] ORDER
BAYER CORP., an Indiana corporation;
BAYER HEALTHCARE LLC, a Delaware
company; BAYER ESSURE INC. (F/K/A
CONCEPTUS, INC.), a Delaware corporation;
BAYER HEALTHCARE
PHARMACEUTICALS, INC., a Delaware
corporation; and DOES 1-10, inclusive,
Defendants.
28
JOINT STIPULATION TO REMAND; CASE NO. 3:17-cv-02230-WHA
1
Plaintiffs Leanna Blankenship, et al., and defendants and specially-appearing defendants
2
Bayer Corporation, Bayer Essure Inc., Bayer HealthCare LLC, and Bayer HealthCare
3
Pharmaceuticals Inc. (collectively, “Bayer”), hereby stipulate and agree as follows:
4
1.
Plaintiffs filed their initial Complaint on March 10, 2017, and their First Amended
5
Complaint on March 21, 2017, in the Superior Court for the State of California, County of
6
Riverside. In their Complaint and First Amended Complaint, Plaintiffs asserted claims involving
7
the Essure® Permanent Birth Control System (the “Essure® Device”).
8
9
10
11
12
13
2.
On April 3, 2017, the Coordination Trial Judge of the Superior Court of the State of
California, County of Alameda, granted Plaintiffs’ petition for coordination of add-on case with the
Judicial Council Coordinated Proceeding (“JCCP”) 4887.
3.
On April 21, 2017, Bayer removed the matter from the Alameda County Superior
Court to the United States District Court for the Northern District of California.
4.
On April 21, 2017, Bayer filed an administrative motion to relate this matter to
14
another matter pending in the Northern District of California involving the Essure® Device,
15
captioned as Elizabeth Ann Sangimino, et al. v. Bayer Corp., et al., Case No. 3:17-cv-01488-WHA.
16
17
18
5.
Bayer filed its Motion to Dismiss on April 28, 2017, on the grounds of federal
preemption, among other grounds.
6.
On May 3, 2017 the parties filed a stipulation to stay briefing on Plaintiffs’
19
anticipated Motion to Remand, and on Defendants’ Motion to Dismiss pending the Northern
20
District of California’s rulings on the Motion to Dismiss and Motion to Remand in Sangimino. The
21
Court granted the parties’ Stipulation on May 4, 2017.
22
7.
On May 19, 2017, Plaintiffs moved to remand this action to the Superior Court of
23
Alameda County, State of California, pursuant to 28 U.S.C. § 1447, on the grounds that this Court
24
lacks jurisdiction over this action.
25
26
8.
On June 9, 2017, this Court granted Plaintiffs’ Motion to Remand in the Sangimino
matter and denied the Motion to Dismiss as moot.
27
28
1
JOINT STIPULATION TO REMAND; CASE NO. 3:17-cv-02230-WHA
1
2
3
4
5
6
9.
The parties have met and conferred and agree to remand this case to the Alameda
County Superior Court.
10.
The parties thus respectfully ask the Court to enter an order remanding this case to
state court based on the stipulation of the parties.
IT IS SO STIPULATED.
Dated: June 19, 2017
7
By: /s/Laura J. Baughman
Laura J. Baughman
Sindhu S. Daniel
Russell W. Budd
8
9
Attorneys for Plaintiffs
10
11
12
13
14
15
16
BARON & BUDD, P.C.
Dated: June 19, 2017
SIDLEY AUSTIN LLP
By: /s/Alycia A. Degen
Alycia A. Degen
Bradley J. Dugan
Attorneys for Defendants and Specially Appearing
Defendants Bayer Corporation, Bayer HealthCare
LLC, Bayer Essure Inc., and Bayer HealthCare
Pharmaceuticals Inc.
17
18
19
20
21
22
23
24
25
26
27
28
2
JOINT STIPULATION TO REMAND; CASE NO. 3:17-cv-02230-WHA
1
2
3
4
5
6
UNITED STATES DISTRICT COURT
7
NORTHERN DISTRICT OF CALIFORNIA
8
9
LEANNA BLANKENSHIP, et al;
10
11
12
13
14
15
16
17
CASE NO. 3:17-cv-02230-WHA
Plaintiffs,
[PROPOSED] ORDER RE JOINT
STIPULATION TO REMAND
v.
BAYER CORP., an Indiana corporation;
BAYER HEALTHCARE LLC, a Delaware
company; BAYER ESSURE INC. (F/K/A
CONCEPTUS, INC.), a Delaware corporation;
BAYER HEALTHCARE
PHARMACEUTICALS, INC., a Delaware
corporation; and DOES 1-10, inclusive,
Defendants.
18
19
20
PURSUANT TO THE PARTIES’ STIPULATION, and for good cause shown, IT IS
21
ORDERED THAT Blankenship v. Bayer Corporation, Case No. 3:17-cv-02230-WHA, be
22
remanded to the Superior Court of the State of California, County of Alameda.
23
June 20, 2017.
DATED: __________________
___________________________________
Honorable William Alsup
24
25
26
27
28
1
[PROPOSED] ORDER RE JOINT STIPULATION TO REMAND - CASE NO. 3:17-cv-02230-WHA
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?